Wing H Tong (Wing Tong)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 16

Top Topics

Medical Students

Newly Diagnosed

Acute Lymphoblastic Leukemia

Cerebrospinal Fluid

Top Venues

Pediatric blood & cancer

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Annemarie Moll-Jongerius, Kirsten Langeveld, Wing H Tong, Tahir Masud, Anneke W M Kramer, Wilco P Achterberg
Professional identity formation of medical students in relation to the care of older persons: a review of the literature. Gerontology & geriatrics education (2023)
Wing H Tong, Bart J Mertens
Comment on 'risk factors associated with nausea and vomiting in children with cancer receiving chemotherapy'. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)
Wing H Tong, Bart J Mertens
More Updates to Come of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial: Could the Statistical Methodology Be Further Improved? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Wing H Tong, Bistra I Veleva, Jan Tjeerd H N de Faber
Comment on: Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemia. Pediatric blood & cancer 69 (11) (2022)
Wing H Tong
Comment on "Correlation of L-asp Activity, Anti-L-asp Antibody, asn and gln with Adverse Events Especially Anaphylaxis Risks in PEG-asp-Contained Regime Treated Pediatric ALL". Technology in cancer research & treatment 20 (2022)
Wing H Tong, Montserrat Mesegué, José Luís Dapena, Mireia Camós, Susana Rives
Native E. coli asparaginase upfront should be replaced by PEGasparaginase upfront in the treatment of pediatric patients with acute lymphoblastic leukemia. Hematological oncology 40 (4) (2022)
Jenny T van der Steen, Wing H Tong, Janneke Groothuijse, Belinda W C Ommering
Perceptions and Motivation Regarding Performing Research in Physicians Specializing in Care for Older Adults Involved in a Mandatory Evidence-Based Medicine Training Study: A Mixed-Methods Study. Advances in medical education and practice 13 (2022)
Wing H Tong, Yiwei Liu
Does L-asparaginase dose intensity correlate with acute pancreatitis in acute lymphoblastic leukemia patients? Pediatric research 92 (2) (2022)
Wing H Tong
Comment on: "Citrulline as a biomarker of bacteraemia during treatment for childhood acute lymphoblastic leukaemia". Pediatric blood & cancer (2021)
Wing H Tong
Does anticoagulation prophylaxis reduce the rate of venous thromboembolism in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy? British journal of haematology (2021)
Wing H Tong
Comment on 'asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly diagnosed acute lymphoblastic leukemia'. Leukemia & lymphoma (2021)
Wing H Tong
Comment on "Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase". Cancer chemotherapy and pharmacology 88 (5) (2021)
Wing H Tong
Comment on Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (4) (2021)
Wing H Tong, Carin A Uyl-De Groot
Comment on: "Premedication prior to PEG-asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia". Pediatric blood & cancer (2021)
Wing H Tong
Comment on: Treatment-induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: New risk factors to consider. Pediatric blood & cancer 69 (1) (2021)
Wing H Tong
Comment on "Comparison of hypersensitivity rates to intravenous and intramuscular PEGasparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review". Pediatric blood & cancer 68 (12) (2021)